Experience

Innovacell Biotechnologie AG v. University of Pittsburgh*

Innovacell Biotechnologie AG

University of Pittsburgh

Represented Innovacell in opposition related to the use of myoblasts for treating stress urinary incontinence.

Innovacell Biotechnologie AG v. University of Pittsburgh, T 1050/12, EPO

Related Practices

Patent Office Invalidation Proceedings

Patent Oppositions and Appeals

Related Industries

Life Sciences

Biotechnology

*Matter handled prior to joining Finnegan

Related Experiences

Innovacell Biotechnologie AG v. University of Pittsburgh*

Innovacell Biotechnologie AG

Innovacell AG v. University of Pittsburgh*

Innovacell AG

Finnegan client BTG prevails in EPO opposition proceedings in the field of vein sclerotherapy

BTG International, Ltd.

Medinol v. Abbott

Abbott

Hyundai Electronics v. Siemens AG

Hyundai Electronics

Pfizer Inc. v. Bayer AG

GlaxoSmithKline

Represented a medical devices company before German Civil Courts and the European Patent Office (EPO)*

Certain Dynamic Random Access Memory Semiconductors 

Elpida Memory, Inc. et. al.

Aloft Media, LLC v. SAP AG

SAP AG

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.